BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8890105)

  • 1. Agammaglobulinemia and insights into B-cell differentiation.
    Manis J; Schwartz RS
    N Engl J Med; 1996 Nov; 335(20):1523-5. PubMed ID: 8890105
    [No Abstract]   [Full Text] [Related]  

  • 2. [Agammaglobulinemia as early B cell defects].
    Miyawaki T; Kanegane H; Futatani T
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Oct; 23(5):435-44. PubMed ID: 11155713
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia.
    Yel L; Minegishi Y; Coustan-Smith E; Buckley RH; Trübel H; Pachman LM; Kitchingman GR; Campana D; Rohrer J; Conley ME
    N Engl J Med; 1996 Nov; 335(20):1486-93. PubMed ID: 8890099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell-deficient muMT mice as an experimental model for Mycoplasma infections in X-linked agammaglobulinemia.
    Berglöf A; Sandstedt K; Feinstein R; Bölske G; Smith CI
    Eur J Immunol; 1997 Aug; 27(8):2118-21. PubMed ID: 9295053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autosomal recessive agammaglobulinemia].
    Kanegane H; Miyawaki T
    Ryoikibetsu Shokogun Shirizu; 2000; (32):63-5. PubMed ID: 11212824
    [No Abstract]   [Full Text] [Related]  

  • 6. IgH repertoire and Ig-related gene expression in X-linked agammaglobulinemia.
    Schiff C; Milili M; Le Deist F; De Saint-Basile G; Fischer A; Fougereau M
    Immunodeficiency; 1993; 4(1-4):3-12. PubMed ID: 8167721
    [No Abstract]   [Full Text] [Related]  

  • 7. Correction of the molecular defect in B lymphocytes from X-linked agammaglobulinemia by cell fusion.
    Schwaber J; Koenig N; Girard J
    J Clin Invest; 1988 Oct; 82(4):1471-6. PubMed ID: 3139715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lymphocytes from X-linked agammaglobulinemia. Delayed expression of light chain and demonstration of Lyonization in carriers.
    Schwaber J; Payne J; Chen R
    J Clin Invest; 1988 Feb; 81(2):514-22. PubMed ID: 3123521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
    de Weers M; Verschuren MC; Kraakman ME; Mensink RG; Schuurman RK; van Dongen JJ; Hendriks RW
    Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the gene defect in X-linked agammaglobulinemia.
    Conley ME; Brown P; Pickard AR; Buckley RH; Miller DS; Raskind WH; Singer JW; Fialkow PJ
    N Engl J Med; 1986 Aug; 315(9):564-7. PubMed ID: 3488506
    [No Abstract]   [Full Text] [Related]  

  • 11. B cells in patients with X-linked agammaglobulinemia.
    Conley ME
    J Immunol; 1985 May; 134(5):3070-4. PubMed ID: 3920309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the pre-BCR complex in a large cohort of patients affected by autosomal-recessive agammaglobulinemia.
    Ferrari S; Zuntini R; Lougaris V; Soresina A; Sourková V; Fiorini M; Martino S; Rossi P; Pietrogrande MC; Martire B; Spadaro G; Cardinale F; Cossu F; Pierani P; Quinti I; Rossi C; Plebani A
    Genes Immun; 2007 Jun; 8(4):325-33. PubMed ID: 17410177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cells in patients with X-linked and 'common variable' hypogammaglobulinaemia.
    Golay JT; Webster AD
    Clin Exp Immunol; 1986 Jul; 65(1):100-4. PubMed ID: 3539422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe primary antibody deficiency due to a novel mutation of mu heavy chain.
    Mohammadzadeh I; Yeganeh M; Aghamohammadi A; Parvaneh N; Behniafard N; Abolhassani H; Tabassomi F; Hemmat M; Kanegane H; Miyawaki T; Ohara O; Rezaei N
    J Investig Allergol Clin Immunol; 2012; 22(1):78-9. PubMed ID: 22448464
    [No Abstract]   [Full Text] [Related]  

  • 15. Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation.
    Fearon ER; Winkelstein JA; Civin CI; Pardoll DM; Vogelstein B
    N Engl J Med; 1987 Feb; 316(8):427-31. PubMed ID: 2880293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked agammaglobulinemia: clinical and immunologic evaluation of six patients.
    Ersoy F; Sanal O; Tezcan I; Berkel AI
    Turk J Pediatr; 1990; 32(4):241-7. PubMed ID: 2135677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoid cell lines from patients with "non-secretory" agammaglobulinemia produce glycosylated heavy chains which are reduced in molecular weight.
    Schwaber J; Rosen FS
    J Mol Cell Immunol; 1984; 1(5):279-91. PubMed ID: 6443854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early B cell development requires mu signaling.
    Iglesias A; Nichogiannopoulou A; Williams GS; Flaswinkel H; Köhler G
    Eur J Immunol; 1993 Oct; 23(10):2622-30. PubMed ID: 8405063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig.
    Topham DJ; Tripp RA; Hamilton-Easton AM; Sarawar SR; Doherty PC
    J Immunol; 1996 Oct; 157(7):2947-52. PubMed ID: 8816401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
    Lau YL; Shields JG; Levinsky RJ; Callard RE
    Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.